Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved
Retrieved on:
Thursday, September 29, 2022
Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved
Key Points:
- Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved
Hardman & Co Research on Advanced Oncotherapy:
AVOs goal is to deliver an affordable and novel PT system, called LIGHT, based on state-of-the-art technology, developed originally at the world-renowned CERN. - The complex assembly of its first LIGHT accelerator in Daresbury has been completed and demonstrated to generate a full-energy proton beam (230MeV) required to treat deep-seated tumours.
- AVO is now working with its clinical partner, University Hospitals Birmingham NHS Foundation Trust (UHB), to commission the treatment room and prepare for regulatory certification.
- This significant de-risking of the project paves the way for further commercial deals.